Status: current, Defined. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4825571000168119 | lenacapavir 300 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4825581000168116 | lenacapavir 300 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| lenacapavir 300 mg tablet | Is a | lenacapavir | true | Inferred relationship | Some | ||
| lenacapavir 300 mg tablet | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| lenacapavir 300 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| lenacapavir 300 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 618724880 | |
| lenacapavir 300 mg tablet | has intended active ingredient | lenacapavir | true | Inferred relationship | Some | 1602887523 | |
| lenacapavir 300 mg tablet | has Australian BoSS | lenacapavir | true | Inferred relationship | Some | 1602887523 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sunlenca 300 mg tablet | Is a | True | lenacapavir 300 mg tablet | Inferred relationship | Some | |
| lenacapavir 300 mg tablet, 5 | has MPUU | True | lenacapavir 300 mg tablet | Inferred relationship | Some | 1164496197 |
Reference Sets
Medicinal product unit of use reference set
FHIR